Is PPBT or PRAX more undervalued in 2026?

CirclFi compares Purple Biotech Ltd. (PPBT) and Praxis Precision Medicines, Inc (PRAX) using 13 institutional-grade valuation models. PPBT has a Quality of Company score of 3.6/10 while PRAX scores 5.6/10.

Which is a better buy — PPBT or PRAX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do PPBT and PRAX valuations compare?

PPBT at $2.81 and PRAX at $352.63 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

PPBT vs PRAX Valuation Comparison 2026 — Intrinsic Value Analysis

PPBT

Biotechnology

Purple Biotech Ltd.

Quality

3.6

out of 10

Value Trap

—

Price

$2.81

Last close

Models

2/13

Active

PRAX

Biotechnology

Praxis Precision Medicines, Inc

Quality

5.6

out of 10

Value Trap

SAFE

Price

$352.63

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	PPBT Fair Value	PPBT Upside	PRAX Fair Value	PRAX Upside
Bayesian DCF	Intrinsic	—	—	$116.77	-66.9%
Earnings Power Value	Intrinsic	—	—	$151.65	-56.0%
EROIC Spread	Intrinsic	$1.34	-52.3%	$130.67	-62.1%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.54	-80.7%	$15.26	-95.6%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for PPBT vs PRAX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

PPBT vs PRAX — Which Stock Is More Undervalued?

PRAX scores higher with a 5.6/10 quality rating vs PPBT's 3.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Purple Biotech Ltd. (PPBT) and Praxis Precision Medicines, Inc (PRAX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

PPBT currently trades at $2.81 with a QOC of 3.6/10, while PRAX trades at $352.63 with a QOC of 5.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).